108 related articles for article (PubMed ID: 29498405)
61. Tim-3 is upregulated in human colorectal carcinoma and associated with tumor progression.
Yu M; Lu B; Liu Y; Me Y; Wang L; Zhang P
Mol Med Rep; 2017 Feb; 15(2):689-695. PubMed ID: 28035413
[TBL] [Abstract][Full Text] [Related]
62. MicroRNA-124 reduces the pentose phosphate pathway and proliferation by targeting PRPS1 and RPIA mRNAs in human colorectal cancer cells.
Qiu Z; Guo W; Wang Q; Chen Z; Huang S; Zhao F; Yao M; Zhao Y; He X
Gastroenterology; 2015 Nov; 149(6):1587-1598.e11. PubMed ID: 26248089
[TBL] [Abstract][Full Text] [Related]
63. Epithelial but not stromal expression of collagen alpha-1(III) is a diagnostic and prognostic indicator of colorectal carcinoma.
Wang XQ; Tang ZX; Yu D; Cui SJ; Jiang YH; Zhang Q; Wang J; Yang PY; Liu F
Oncotarget; 2016 Feb; 7(8):8823-38. PubMed ID: 26741506
[TBL] [Abstract][Full Text] [Related]
64. Overexpression of lncRNA AFAP1-AS1 correlates with poor prognosis and promotes tumorigenesis in colorectal cancer.
Wang F; Ni H; Sun F; Li M; Chen L
Biomed Pharmacother; 2016 Jul; 81():152-159. PubMed ID: 27261589
[TBL] [Abstract][Full Text] [Related]
65. Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.
Li J; Chen Y; Guo X; Zhou L; Jia Z; Tang Y; Lin L; Liu W; Ren C
Tumour Biol; 2016 Jul; 37(7):8765-73. PubMed ID: 26743779
[TBL] [Abstract][Full Text] [Related]
66. Metalloproteases meprin-ɑ (MEP1A) is a prognostic biomarker and promotes proliferation and invasion of colorectal cancer.
Wang X; Chen J; Wang J; Yu F; Zhao S; Zhang Y; Tang H; Peng Z
BMC Cancer; 2016 Jul; 16():383. PubMed ID: 27378469
[TBL] [Abstract][Full Text] [Related]
67. Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy.
Lee YC; Su CY; Lin YF; Lin CM; Fang CY; Lin YK; Hsiao M; Chen CL
Oncotarget; 2017 Feb; 8(7):12120-12132. PubMed ID: 28076332
[TBL] [Abstract][Full Text] [Related]
68. Up-regulation of
Ueda M; Iguchi T; Masuda T; Komatsu H; Nambara S; Sakimura S; Hirata H; Uchi R; Eguchi H; Ito S; Sugimachi K; Mizushima T; Doki Y; Mori M; Mimori K
Anticancer Res; 2017 May; 37(5):2255-2263. PubMed ID: 28476790
[TBL] [Abstract][Full Text] [Related]
69. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
[TBL] [Abstract][Full Text] [Related]
70. The significance of PITX2 overexpression in human colorectal cancer.
Hirose H; Ishii H; Mimori K; Tanaka F; Takemasa I; Mizushima T; Ikeda M; Yamamoto H; Sekimoto M; Doki Y; Mori M
Ann Surg Oncol; 2011 Oct; 18(10):3005-12. PubMed ID: 21479692
[TBL] [Abstract][Full Text] [Related]
71. Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival.
Hägglöf C; Hammarsten P; Josefsson A; Stattin P; Paulsson J; Bergh A; Ostman A
PLoS One; 2010 May; 5(5):e10747. PubMed ID: 20505768
[TBL] [Abstract][Full Text] [Related]
72. Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis.
Miyoshi N; Ishii H; Mimori K; Takatsuno Y; Kim H; Hirose H; Sekimoto M; Doki Y; Mori M
Br J Cancer; 2009 Nov; 101(10):1664-70. PubMed ID: 19904274
[TBL] [Abstract][Full Text] [Related]
73. Stromal Platelet-Derived Growth Factor Receptor-β Signaling Promotes Breast Cancer Metastasis in the Brain.
Thies KA; Hammer AM; Hildreth BE; Steck SA; Spehar JM; Kladney RD; Geisler JA; Das M; Russell LO; Bey JF; Bolyard CM; Pilarski R; Trimboli AJ; Cuitiño MC; Koivisto CS; Stover DG; Schoenfield L; Otero J; Godbout JP; Chakravarti A; Ringel MD; Ramaswamy B; Li Z; Kaur B; Leone G; Ostrowski MC; Sizemore ST; Sizemore GM
Cancer Res; 2021 Feb; 81(3):606-618. PubMed ID: 32327406
[TBL] [Abstract][Full Text] [Related]
74. Upregulation of the growth arrest-specific-2 in recurrent colorectal cancers, and its susceptibility to chemotherapy in a model cell system.
Huang CJ; Lee CL; Yang SH; Chien CC; Huang CC; Yang RN; Chang CC
Biochim Biophys Acta; 2016 Jul; 1862(7):1345-53. PubMed ID: 27085973
[TBL] [Abstract][Full Text] [Related]
75. Radiobrominated benzimidazole-quinoline derivatives as Platelet-derived growth factor receptor beta (PDGFRβ) imaging probes.
Effendi N; Mishiro K; Takarada T; Makino A; Yamada D; Kitamura Y; Shiba K; Kiyono Y; Odani A; Ogawa K
Sci Rep; 2018 Jul; 8(1):10369. PubMed ID: 29991770
[TBL] [Abstract][Full Text] [Related]
76. Assessment of PDGFRβ promoter methylation in canine osteosarcoma using methylation-sensitive high-resolution melting analysis.
Gentilini F; Capitani O; Tinto D; Rigillo A; Sabattini S; Bettini G; Turba Maria E
Vet Comp Oncol; 2020 Dec; 18(4):484-493. PubMed ID: 31950560
[TBL] [Abstract][Full Text] [Related]
77. Crenolanib, a PDGFR inhibitor, suppresses lung cancer cell proliferation and inhibits tumor growth in vivo.
Wang P; Song L; Ge H; Jin P; Jiang Y; Hu W; Geng N
Onco Targets Ther; 2014; 7():1761-8. PubMed ID: 25328409
[TBL] [Abstract][Full Text] [Related]
78. Peptide-based targeting of the platelet-derived growth factor receptor beta.
Askoxylakis V; Marr A; Altmann A; Markert A; Mier W; Debus J; Huber PE; Haberkorn U
Mol Imaging Biol; 2013 Apr; 15(2):212-21. PubMed ID: 22791264
[TBL] [Abstract][Full Text] [Related]
79. Peptide arrays for development of PDGFRβ Affine molecules.
Marr A; Nissen F; Maisch D; Altmann A; Rana S; Debus J; Huber PE; Haberkorn U; Askoxylakis V
Mol Imaging Biol; 2013 Aug; 15(4):391-400. PubMed ID: 23381728
[TBL] [Abstract][Full Text] [Related]
80.
Miyoshi N; Yamamoto H; Mimori K; Yamashita S; Miyazaki S; Nakagawa S; Ishii H; Noura S; Ohue M; Yano M; Doki Y; Mori M
Oncol Lett; 2014 Nov; 8(5):2313-2317. PubMed ID: 25289111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
